All Articles

Antitrust & Competition

Competition Law's Season of Uncertainty

New laws, new regulators and a new wave of nationalism is roiling the global competition waters. Tim Cornell and Sharis Pozen, leaders of Clifford Chance’s U.S. and Global Antitrust groups respectively, discuss the challenges of multijurisdictional merger review, snowballing investigations and other hot-button issues in the global antitrust arena.

Read More

Career Development

Investing in Relationships Around the Globe

Jennifer Pastarnack, associate at Clifford Chance, discusses her work in the firm’s global distressed debt trading practice, including the importance of knowing the real people behind the deal. 

Read More


Now Is the Time for Companies to Assess Their Compliance Programs

Michelle Williams of Clifford Chance’s litigation, regulatory and white collar practice group, discusses recent enforcement actions taken by the Office of Foreign Assets Control (OFAC) – and what companies can do to proactively improve their compliance programs.

Read More

Cybersecurity | Risk Management

Questions About Cybersecurity? There's an App for That!

Dan Silver and Megan Gordon, partners with Clifford Chance, discuss the firm’s cross-border, cross-practice approach to handling cybersecurity and dataprivacy issues.

Read More


The Pros & Cons of the OCC's New FinTech Charter

  Special purpose bank charters preempt the patchwork of state laws, but challenges from state bank regulators could cloud the future. The Office of the Comptroller of the Currency (OCC) recently announced that it will begin accepting special purpose national bank charter...

Read More


Fast Take: Future Legal Frameworks for AI

  The development of robotics will go hand in hand with rapid development in AI and near-zero latency telecom infrastructure. Autonomous robotics using deep AI will revolutionize the industry and the home, creating the need for substantive regulations regarding security, safety and privacy....

Read More

Life Sciences

M&A Surges as Strategic Buyers Seek Next Big Thing in Life Sciences

Clifford Chance’s Benjamin Sibbett and Daryl Fairbairn discuss the nature of M&A in the industry—today and tomorrow. CCBJ: What are the market trends in the life sciences M&A space? Daryl Fairbairn: Most M&A in the life sciences sector is executed by strategic buyers...

Read More